- Home
- AUTL vs QSI Comparison
AUTL vs QSI Comparison
Compare AUTL & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- QSI
- Stock Information
- Founded
- AUTL 2014
- QSI 2013
- Country
- AUTL United Kingdom
- QSI United States
- Employees
- AUTL N/A
- QSI N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- AUTL Health Care
- QSI Health Care
- Exchange
- AUTL Nasdaq
- QSI Nasdaq
- Market Cap
- AUTL 609.4M
- QSI 633.2M
- IPO Year
- AUTL 2018
- QSI N/A
- Fundamental
- Price
- AUTL $2.22
- QSI $2.24
- Analyst Decision
- AUTL Strong Buy
- QSI Buy
- Analyst Count
- AUTL 3
- QSI 2
- Target Price
- AUTL $10.20
- QSI $3.25
- AVG Volume (30 Days)
- AUTL 1.4M
- QSI 60.4M
- Earning Date
- AUTL 03-13-2025
- QSI 02-27-2025
- Dividend Yield
- AUTL N/A
- QSI N/A
- EPS Growth
- AUTL N/A
- QSI N/A
- EPS
- AUTL N/A
- QSI N/A
- Revenue
- AUTL $10,091,000.00
- QSI $2,266,000.00
- Revenue This Year
- AUTL $851.83
- QSI $193.90
- Revenue Next Year
- AUTL $264.18
- QSI $173.18
- P/E Ratio
- AUTL N/A
- QSI N/A
- Revenue Growth
- AUTL 82.71
- QSI 232.26
- 52 Week Low
- AUTL $2.07
- QSI $0.61
- 52 Week High
- AUTL $7.37
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- AUTL 38.18
- QSI 49.02
- Support Level
- AUTL $2.18
- QSI $1.85
- Resistance Level
- AUTL $2.38
- QSI $2.68
- Average True Range (ATR)
- AUTL 0.16
- QSI 0.83
- MACD
- AUTL 0.01
- QSI -0.15
- Stochastic Oscillator
- AUTL 7.94
- QSI 9.95
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.